Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans
about
Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alikeNoncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and BiomarkersThe aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cellsTransgenic and gene knockout mice in gastric cancer researchmiR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesisTH17, TH22 and Treg cells are enriched in the healthy human cecum.Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis.Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.TFF1 activates p53 through down-regulation of miR-504 in gastric cancerA synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion.An increase in integrin-linked kinase non-canonically confers NF-κB-mediated growth advantages to gastric cancer cells by activating ERK1/2.Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis.Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses.Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis.Immunotoxic effects of thymus in mice following exposure to nanoparticulate TiO2.The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas.Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients.Mouse models of gastric cancer.Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS productionAurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia.HDM2 regulation by AURKA promotes cell survival in gastric cancer.Mouse models for gastric cancer: Matching models to biological questions.Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer.Trefoil factor family peptides--friends or foes?Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer.Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia.Activation of the NF-kB pathway downregulates TFF-1 in gastric carcinogenesis.Inhibition of TGF-β and EGF pathway gene expression and migration of oral carcinoma cells by mucosa-associated lymphoid tissue 1.NF-κB Signaling in Gastric Cancer.Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death.Epigenetic and genetic variation in GATA5 is associated with gastric disease riskLoss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia.Chemokines and antimicrobial peptides have a cag-dependent early response to Helicobacter pylori infection in primary human gastric epithelial cells.Metaplasia in the Stomach-Precursor of Gastric Cancer?TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells.Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.
P2860
Q26769946-C889FBE1-006A-4BF9-B3D0-E46E2796D524Q26785700-9B87481C-CB76-4A97-AEDD-3EE7264A7BEFQ27851718-5D2A393C-8F16-49AC-8A9B-46EDFF8586BEQ28074847-4F7BAAE8-4823-4875-A1F3-F846E157B575Q28384791-729A63B4-BA5F-46E9-8E8D-B947793207F7Q31076852-0E3D76C6-8A1E-427B-8965-D2A8296B4708Q33705487-E5560EC0-23C9-4831-9F4D-6BF403A475B4Q33794355-2AFC4361-9968-4B30-8A99-2D4B471AF867Q33827698-9FCB0457-FEC9-4E30-92A2-C13336B9E7DFQ34221596-FD2ACCAA-E4F9-4282-B04B-A66ACE1F8EE0Q34583126-FBC9ABCB-48F7-48CC-A19E-89F88E9FEE61Q34629975-BC3D9A7F-41AA-411A-94D8-F1DD8F00F4DFQ35061777-15590D0B-B4F0-4413-ABB6-5BEB60223A63Q36228457-2E742C29-74FA-4AF7-B2BC-7870B19C1661Q36279983-C4E4952C-7ABE-476C-A34A-0A748CAFEF32Q36348877-02264672-730B-47DF-9FE0-77F2C1593335Q36413804-A93D9ED9-F6A9-4454-9297-67FD79D94DD0Q36472693-60EE30B7-A858-4564-A22A-620C361B4BA8Q36715308-25AED1FD-0DB0-4DED-863D-1FDFDBC74ED1Q37061732-BED4C515-5542-4C5D-AB10-B8CEBCAF96D2Q37212025-894B6999-51C8-4DE7-A5A7-9F26B531735BQ37341585-6026A767-78EE-4501-90D5-DE6173F336D0Q37626244-FF89FA29-48BB-4605-BC1B-98CABBF4AC6CQ37664258-793520F7-7111-4599-A169-795924072C0DQ37678094-39FBCD76-0DCC-43B9-A35A-70F4F6FD7F81Q38478183-1A8DACD9-7809-43B7-ACF2-29BD84E4377BQ38610757-28FAA034-3B61-44F3-AC92-EFFD9C5E4935Q38798656-CBED5595-A6A0-4F8F-A983-E0E642494562Q38911746-E523ABDD-6EBE-4BC2-B2FC-A694C8E5267CQ38915431-A3C51210-A3A5-46F4-BE81-BE68D159B1ACQ39110604-A297CC96-84C0-4B2E-A9B4-9590D37A772BQ39137843-64EC36B6-2689-4590-8B05-3A8F6E72C5EBQ39204794-F0515A9A-7DB9-4A98-8653-318C4799576CQ40187780-C0891D78-CF53-4C59-91D9-1040F7345723Q40659698-7CA59E91-1E00-4694-837F-DBA00D9E7D57Q41243646-FF563336-A690-4DD4-96F4-6BC945899686Q42735507-859BA80D-0CD5-43C2-8ED8-4E86B478D1FCQ47107972-24586520-F6E3-450D-BB21-11EC64614DA3Q47140299-C8921AA3-FADC-4BB1-AA05-41B0EA8D657CQ48158439-C52F1533-AD3B-4548-989A-6AAA5E0AEA28
P2860
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@ast
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@en
type
label
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@ast
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@en
prefLabel
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@ast
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@en
P2093
P2860
P356
P1476
Loss of TFF1 is associated wit ...... c neoplasia in mice and humans
@en
P2093
Abbes Belkhiri
Aixiang Jiang
Alexander Zaika
Dunfa Peng
M Blanca Piazuelo
M Kay Washington
Pelayo Correa
Richard M Peek
Sheila E Crowe
Wael El-Rifai
P2860
P304
P356
10.1172/JCI43922
P407
P577
2011-04-01T00:00:00Z